文献速递中医内科中药与中成药合理使用

金芪降糖片:化学成分、质量控制、药代动力学、药理作用与临床应用综述

A Chinese medicine formula (Jinqi Jiangtang Tablet): A review on its chemical constituents, quality control, pharmacokinetics studies, pharmacological properties and clinical applications.
PubMed 文献 · J Ethnopharmacol · 2019-02-22

该综述系统梳理了金芪降糖片(由黄连、黄芪、金银花组成)的化学成分、质量控制、药代动力学、药理特性与临床应用,指出其质量控制体系不完善、药理机制未充分阐明、临床证据需再评价,并提出结合生物评价、肠道菌群、多组分药代动力学及循证医学再验证等未来方向。

要点

  • 金芪降糖片由黄连、黄芪、金银花组成,随机双盲安慰剂对照试验证明其治疗糖尿病有效。
  • 现有研究问题包括质控体系不完善、药理机制未充分阐明、临床证据需再评价。
  • 未来方向包括化学-生物联合质控、肠道菌群、多组分药代及循证医学再评价。

核心结论

  • 金芪降糖片作为经典方剂二次开发有重要价值,但需解决质控、机制和临床再评价问题。

研究设计与样本

  • 综述检索PubMed、Google Scholar、Science Direct、Wiley、Web of Science、CNKI、万方等数据库,并参考药典、经典本草及上市后再评价报告。

主要发现

  • 金芪降糖片由黄连、黄芪、金银花三味中药组成,随机双盲安慰剂对照试验证明其治疗糖尿病有效。
  • 现有研究存在质控体系不完善、药理机制未充分阐明、临床应用需再评价等问题。

临床怎么用

  • 临床可基于随机双盲安慰剂对照试验证据,将金芪降糖片用于糖尿病治疗。

局限性

  • 质量控制体系不完善,药理功能机制未充分解释,临床应用需再评价。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Diabetes belongs to the category of "Xiao Ke Zheng" in the field of traditional Chinese medicine (TCM) and has been listed as one of the predominant diseases of TCM. Jinqi Jiangtang Tablet (JQJTT), a Chinese medicine formula composed of three herbs (Coptis chinensis, Astragalus membranaceus and Lonicera japonica), is an effective prescription for diabetes proved by randomized, double-blind, placebo-controlled trials. AIM OF THE REVIEW: To analyze systematic and up-to-date classification information on the study of JQJTT, explain the problems existing in the current research of classics formulas, and further propose the solution, providing a reference for future study. MATERIALS AND METHODS: Literatures on JQJTT were collected from a variety of databases, including PubMed, Google Scholar, Science Direct, Wiley, Web of Science, China National Knowledge Infrastructure, and WanFang Data. Information was also collected from books and reports, such as Chinese Pharmacopoeia, Chinese herbal classic books and reports of re-evaluation on post-marketing drugs conducted by companies. RESULTS: There are some problems for JQJTT: the quality control system is not perfect, the pharmacological functional mechanism is not fully explained, and clinical applications need to be reevaluated. A few of research directions for future research are proposed: (i) the chemical quality evaluation combined with bioassay to evaluate quality; (ii) interaction based on gut microbiota in vivo; (iii) the effects of interaction between components of the polypharmacy on pharmacokinetic studies; (iv) interaction mechanism between drugs and endogenous small molecules and biomacromolecules; (v) evidence-based medicine reconfirmation for clinical evaluation. CONCLUSIONS: The recent research status of JQJTT was summarized and analyzed from the aspects of chemical constituents, quality control, pharmacokinetics studies, pharmacological properties and clinical applications. This review takes JQJTT as an example, points out some typical problems and opinions about the TCM formulas, highlights the importance of the secondary development of classical formula, and lays a foundation for the further research.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Liu Y, Wang A, Wen L, et al. A Chinese medicine formula (Jinqi Jiangtang Tablet): A review on its chemical constituents, quality control, pharmacokinetics studies, pharmacological properties and clinical applications. J Ethnopharmacol. 2019. PMID: 30802612. doi:10.1016/j.jep.2019.02.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。